C M Bidwell & Associates LTD Amneal Pharmaceuticals, Inc. Transaction History
C M Bidwell & Associates LTD
- $189 Million
- Q2 2025
A detailed history of C M Bidwell & Associates LTD transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 65 shares of AMRX stock, worth $635. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65Holding current value
$635% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding AMRX
# of Institutions
249Shares Held
145MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$172 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$121 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$115 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$110 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$55 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.48B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...